In PTZ-induced epileptic models, the knock-out of TRPM2 has shown efficacy in ameliorating epilepsy-induced hippocampal pathological damages, probably via the PARP1 downstream signaling pathway involving BNIP3 [45]. The gene discussed is PARP1; the disease is epilepsy.